Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Shiga toxin (Stx)-producing Escherichia coli (STEC) from patients with hemolytic-uremic syndrome (HUS), patients with diarrhea without HUS, or asymptomatic subjects were genotyped to assess associations between stx2 variants and clinical manifestations of infection. Neither stx2d nor stx2e was found in 268 STEC isolates from patients with HUS. Of 262 STEC isolates from patients with diarrhea, stx(2d) was found in 41 (15.6%; P<.000001), and stx2e was found in 12 (4.6%; P=.0004). The stx2c genotype frequency was similar among isolates from patients with HUS (3.7%) and diarrhea (5.0%). The frequencies of stx2c, stx2d, and stx2e among 96 STEC isolates from asymptomatic subjects were comparable to those among isolates from patients with diarrhea. None of the 626 STEC isolates contained stx2f. All stx2d-positive or stx2e-positive STEC isolates were eae negative and originated from subjects older than those with STEC isolates with stx2c. stx2c-positive STEC isolates can cause HUS, but the presence of stx2d or stx2e may predict a milder disease with a minimal risk of HUS.

[1]  J. Bockemühl,et al.  Infektionen des Menschen durch enterohämorrhagische Escherichia coli (EHEC) in der Bundesrepublik Deutschland von 1998 bis 2001 Prävalenz und Typenspektrum , 2002, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[2]  H. Karch,et al.  Sorbitol-Fermenting Shiga Toxin-Producing Escherichia coli O157:H− Strains: Epidemiology, Phenotypic and Molecular Characteristics, and Microbiological Diagnosis , 2001, Journal of Clinical Microbiology.

[3]  S. Djordjevic,et al.  The Common Ovine Shiga Toxin 2-ContainingEscherichia coli Serotypes and Human Isolates of the Same Serotypes Possess a Stx2d Toxin Type , 2001, Journal of Clinical Microbiology.

[4]  H. Karch,et al.  Non-O157:H7 Shiga toxin (verocytotoxin)-producing Escherichia coli strains: epidemiological significance and microbiological diagnosis , 2000 .

[5]  H. Karch,et al.  Characterization of a Shiga Toxin 2e-Converting Bacteriophage from an Escherichia coli Strain of Human Origin , 2000, Infection and Immunity.

[6]  L. Hoelzle,et al.  Characterization of shiga toxin type 2 variant B‐subunit in Escherichia coli strains from asymptomatic human carriers by PCR‐RFLP , 2000, Letters in applied microbiology.

[7]  Craig S. Wong,et al.  The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. , 2000, The New England journal of medicine.

[8]  H. Karch,et al.  Molecular Characteristics and Epidemiological Significance of Shiga Toxin-Producing Escherichia coliO26 Strains , 2000, Journal of Clinical Microbiology.

[9]  H. Karch,et al.  Zur Verbesserung der gegenwärtigen bakteriologischen Diagnostik von enterohämorrhagischen Escherichia coli (EHEC) Stufenplan für klinische und epidemiologische Zwecke , 2000, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[10]  A. Caprioli,et al.  A New Shiga Toxin 2 Variant (Stx2f) fromEscherichia coli Isolated from Pigeons , 2000, Applied and Environmental Microbiology.

[11]  H. Karch,et al.  Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains. , 2000, Journal of clinical microbiology.

[12]  H. Karch,et al.  A Genomic Island, Termed High-Pathogenicity Island, Is Present in Certain Non-O157 Shiga Toxin-Producing Escherichia coli Clonal Lineages , 1999, Infection and Immunity.

[13]  H. Karch,et al.  Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections. , 1999, Diagnostic microbiology and infectious disease.

[14]  S. McEwen,et al.  Associations between Virulence Factors of Shiga Toxin-ProducingEscherichia coli and Disease in Humans , 1999, Journal of Clinical Microbiology.

[15]  M. Petric,et al.  Evaluation of a Microplate Latex Agglutination Method (Verotox-F Assay) for Detecting and Characterizing Verotoxins (Shiga Toxins) in Escherichia coli , 1999, Journal of Clinical Microbiology.

[16]  H. Karch,et al.  Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. , 1999, The Journal of infectious diseases.

[17]  S. Lauwers,et al.  Identification of New Verocytotoxin Type 2 Variant B-Subunit Genes in Human and Animal Escherichia coliIsolates , 1998, Journal of Clinical Microbiology.

[18]  A. O’Brien,et al.  Virulence of Shiga toxin-producing Escherichia coli (STEC) in orally-infected mice correlates with the type of toxin produced by the infecting strain. , 1998, Japanese journal of medical science & biology.

[19]  H. Karch,et al.  Shiga Toxin-Producing Escherichia coli Infections in Germany †. , 1997, Journal of food protection.

[20]  H. Lior,et al.  Isolation and virulence factors of verocytotoxin-producing Escherichia coli in human stool samples. , 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  P. Tarr,et al.  Perspective: the problem of non-O157:H7 shiga toxin (Verocytotoxin)-producing Escherichia coli. , 1996, The Journal of infectious diseases.

[22]  L. Beutin,et al.  Rapid detection and isolation of shiga-like toxin (verocytotoxin)-producing Escherichia coli by direct testing of individual enterohemolytic colonies from washed sheep blood agar plates in the VTEC-RPLA assay , 1996, Journal of clinical microbiology.

[23]  H. Karch,et al.  Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture , 1996, Journal of clinical microbiology.

[24]  H. Karch,et al.  Infektionen des Menschen durch enteroh~imor- rhagische Escherichia coli (EHEC) in Deutschland, , 1996 .

[25]  A. Caprioli,et al.  Clonal relatedness of Shiga-like toxin-producing Escherichia coli O101 strains of human and porcine origin , 1995, Journal of clinical microbiology.

[26]  A. J. Bourne,et al.  Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons , 1995, Infection and immunity.

[27]  A. Caprioli,et al.  Genotyping of Shiga-like toxin genes in non-O157 Escherichia coli strains associated with haemolytic uraemic syndrome. , 1995, Journal of medical microbiology.

[28]  W. L. Payne,et al.  Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR , 1995, Journal of clinical microbiology.

[29]  P. Tarr.  Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  F. Gunzer,et al.  Construction of recombinant Shiga-like toxin-IIv (SLT-IIv) and its use in monitoring the SLT-IIv antibody status of pigs. , 1995, Veterinary microbiology.

[31]  H. Karch,et al.  Prevalence of attaching and effacing Escherichia coli in stool samples from patients and controls. , 1994, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[32]  J. Heesemann,et al.  Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. , 1994, Journal of medical microbiology.

[33]  H. Cavé,et al.  Identification of a clone of Escherichia coli O103:H2 as potential agent of hemolytic-uremic syndrome in France , 1994, Journal of Clinical Microbiology.

[34]  G. Donelli,et al.  Characterisation of verocytotoxin-producing Escherichia coli isolated from pigs and cattle in northern Italy , 1993, Veterinary Record.

[35]  A. Melton,et al.  Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model , 1993, Infection and immunity.

[36]  P. Manning,et al.  Polymerase chain reaction amplification, cloning and sequencing of variant Escherichia coli Shiga-like toxin type II operons. , 1993, Microbial pathogenesis.

[37]  B. Rowe,et al.  Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157 , 1993, Journal of clinical microbiology.

[38]  F. Gunzer,et al.  Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome , 1992, Journal of clinical microbiology.

[39]  M. P. Jackson,et al.  Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. , 1992, Current topics in microbiology and immunology.

[40]  H. Karch,et al.  Serological and biochemical properties of Shiga-like toxin (verocytotoxin)-producing strains of Escherichia coli, other than O-group 157, from patients in Germany. , 1992, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[41]  Jasper Hii,et al.  Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1 , 1991, Journal of clinical microbiology.

[42]  H. Lior,et al.  Diarrhoea associated with Escherichia coli producing porcine oedema disease verotoxin , 1991, The Lancet.

[43]  M. McKee,et al.  Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511 , 1991, Infection and immunity.

[44]  R. Tauxe,et al.  The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. , 1991, Epidemiologic reviews.

[45]  V. Gannon,et al.  Molecular cloning and nucleotide sequence of another variant of the Escherichia coli Shiga-like toxin II family. , 1990, Journal of general microbiology.

[46]  S. Ostroff,et al.  Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. , 1989, The Journal of infectious diseases.

[47]  M. P. Jackson,et al.  Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine , 1988, Journal of bacteriology.

[48]  J. Peiris,et al.  Escherichia coli strains isolated from pigs with edema disease produce a variant of Shiga-like toxin II , 1987 .

[49]  S. Formal,et al.  ESCHERICHIA COLI 0157:H7 STRAINS ASSOCIATED WITH HAEMORRHAGIC COLITIS IN THE UNITED STATES PRODUCE A SHIGELLA DYSENTERIAE 1 (SHIGA) LIKE CYTOTOXIN , 1983, The Lancet.